• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    WORK Medical Technology Group LTD's Subsidiary, Hangzhou Shanyou, Showcases Products at MEDICA Trade Fair 2024

    11/27/24 8:00:00 AM ET
    $WOK
    Medical/Dental Instruments
    Health Care
    Get the next $WOK alert in real time by email

    Hangzhou, China, Nov. 27, 2024 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (NASDAQ:WOK) ("WORK Medical" or the "Company"), a supplier of medical devices in China, today announced that its subsidiary, Hangzhou Shanyou Medical Equipment Co., Ltd. ("Hangzhou Shanyou"), participated in the MEDICA Trade Fair 2024 (the "Event"), held in Düsseldorf, Germany, from November 11 to November 14, 2024. The Event provided a platform through which Hangzhou Shanyou's products could garner interest and attention from international customers. This milestone underscores WORK Medical's strategic commitment to enhancing its global brand visibility and competing internationally in the low- and medium-value medical devices and consumables sectors.

    The Event invites participants from the fields of business, research, and politics. The Event attracted 5,800 exhibiting companies from 72 countries around the world. In addition, the professional forums and conferences have become an integral part of the Event, which also includes special shows on a variety of medical-technological topics.

    During the Event, Hangzhou Shanyou showcased a range of its flagship products, including its non-inflatable laryngeal mask, breathing circuits, and endotracheal tubes. These offerings demonstrated WORK Medical's technological advancements, built on over 20 years of expertise in the medical device industry. The Event provided Hangzhou Shanyou with an opportunity to attract interest from potential global customers while gaining valuable insights into their specific needs. The Company expects that these insights will guide the ongoing refinement of its product portfolio and may steer its R&D efforts, to assist in aligning its global expansion strategies with the evolving demands of the medical device industry.

    Mr. Shuang Wu, Chairman and CEO of WORK Medical, commented, "As we explore global opportunities to drive expansion and long-term success, the Event serves as an excellent platform to showcase our products, enhance our brand image, and engage with international peers to exchange insights on industry trends, technologies, and innovations. Looking ahead, we are committed to accelerating our internationalization, as we seek to secure more global orders and deliver enhanced value to our shareholders by leveraging our production and scale advantages."

    About WORK Medical Technology Group LTD

    WORK Medical Technology Group LTD is a supplier of medical devices that develops and manufactures Class I and II medical devices and sells Class I and II disposable medical devices through operating subsidiaries in China. The Company has a diverse product portfolio comprising 21 products, including customized and multifunctional masks and other medical consumables. All the products have been sold in 34 provincial-level administrative regions in China, with 15 of them sold in more than 30 countries worldwide. The Company has received a number of quality-related manufacturing designations and has registered 17 products with the U.S. Food and Drug Administration allowing their products to enter the U.S. market. For more information, please visit the Company's website: https://www.workmedtech.com/corporate.

    Forward-Looking Statements

    This press release contains forward-looking statements, including statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as "aims," "anticipates," "believes," "could," "estimates," "expects," "forecasts," "goal," "intends," "may," "plans," "possible," "potential," "seeks," "will," and variations of these words or similar expressions that are intended to identify forward-looking statements. Any such statements in this press release that are not statements of historical fact may be deemed to be forward-looking statements.

    Any forward-looking statements in this press release are based on the Company's current expectations, estimates and projections only as of the date of this release and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results set forth in the Company's registration statement on Form F-1 and other documents filed by the Company with the U.S. Securities and Exchange Commission. The Company explicitly disclaims any obligation to update any forward-looking statements except to the extent required by law.

    For more information, please contact:

    WORK Medical Technology Group LTD

    Investor Relations Department

    Email: [email protected]

    Ascent Investor Relations LLC

    Tina Xiao

    Phone: +1-646-932-7242

    Email: [email protected]



    Primary Logo

    Get the next $WOK alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Q&A

    New
    • What significant event did WORK Medical's subsidiary participate in recently?

      WORK Medical's subsidiary, Hangzhou Shanyou, participated in the MEDICA Trade Fair 2024 held in Düsseldorf, Germany.

    • What products did Hangzhou Shanyou exhibit at the MEDICA Trade Fair 2024?

      Hangzhou Shanyou showcased medical devices such as non-inflatable laryngeal masks, breathing circuits, and endotracheal tubes.

    • How large was the attendance and participation at the MEDICA Trade Fair 2024?

      The MEDICA Trade Fair 2024 attracted 5,800 companies from 72 countries and included professional forums and special shows on technological topics.

    • What were the key goals of WORK Medical's participation in the MEDICA Trade Fair according to their CEO?

      Mr. Shuang Wu emphasized that the event was a platform to enhance brand image, engage with international peers, and explore global expansion opportunities.

    • What is the primary focus of WORK Medical Technology Group and how diverse is its product portfolio?

      WORK Medical Technology Group specializes in Class I and II medical devices and has a portfolio of 21 products, with distributions extending to over 30 countries.

    Recent Analyst Ratings for
    $WOK

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $WOK
    SEC Filings

    View All

    Amendment: SEC Form 20-F/A filed by WORK Medical Technology Group LTD

    20-F/A - WORK Medical Technology Group LTD (0001929783) (Filer)

    3/20/26 4:00:26 PM ET
    $WOK
    Medical/Dental Instruments
    Health Care

    SEC Form 6-K filed by WORK Medical Technology Group LTD

    6-K - WORK Medical Technology Group LTD (0001929783) (Filer)

    2/27/26 4:00:38 PM ET
    $WOK
    Medical/Dental Instruments
    Health Care

    SEC Form 6-K filed by WORK Medical Technology Group LTD

    6-K - WORK Medical Technology Group LTD (0001929783) (Filer)

    2/9/26 9:55:09 PM ET
    $WOK
    Medical/Dental Instruments
    Health Care

    $WOK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    WORK Medical Grants East China Exclusive Distribution Rights for AI-Automated Blood Cell Morphology Analyzer, Sets RMB10 Million Sales Target for 2026

    Hangzhou, China, Dec. 29, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (NASDAQ:WOK) ("WORK Medical", the "Company" or "we"), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced that its subsidiary, Hunan Saitumofei Medical Treatment Technology Co., Ltd. ("Hunan Saitumofei") has entered into a one-year exclusive distribution agreement (the "Agreement") with Shanghai Benke Medical Technology Co., Ltd. ("Shanghai Benke") to promote and distribute its newly launched AI-Automated Blood Cell Morphology Analyzer (CM-B600) (the "Analyzer") in East China throughout 2026. Th

    12/29/25 9:35:00 AM ET
    $WOK
    Medical/Dental Instruments
    Health Care

    WORK Medical Technology Group LTD Subsidiary Obtains Manufacturing Approval for Its AI-Automated Blood Cell Morphology Analyzer

    Hangzhou, China, Dec. 29, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (NASDAQ:WOK) ("WORK Medical" or the "Company"), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced that its subsidiary, Hunan Saitumofei Co., Ltd., has received manufacturing approval from the Hunan Provincial Medical Products Administration for its Class II medical device, the Artificial Intelligence ("AI")-Automated Human Blood Cell Morphology Analyzer. This regulatory approval represents a milestone in WORK Medical's research and development strategy and is expected to position the Company's

    12/29/25 9:00:00 AM ET
    $WOK
    Medical/Dental Instruments
    Health Care

    WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective December 29, 2025

    Hangzhou, China, Dec. 24, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (NASDAQ:WOK) ("WORK Medical" or the "Company"), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced that it will effect a reverse stock split of its ordinary shares on a 1-for-100 basis (the "Reverse Stock Split"). The Company's Class A ordinary shares will begin trading on a post-split basis when the market opens on December 29, 2025. The Company's Class A ordinary shares will continue to trade on the Nasdaq Capital Market under the symbol "WOK," with a new CUSIP number G9767H125. The Reverse

    12/24/25 11:30:00 AM ET
    $WOK
    Medical/Dental Instruments
    Health Care